Related references
Note: Only part of the references are listed.High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial
Karen Schreiber et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial
Karen Schreiber et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trialstudy protocol
Ricarda Diem et al.
BMJ OPEN (2016)
Efficacy of combination therapy with erythropoietin and methylprednisolone in clinical recovery of severe relapse in multiple sclerosis
Fatemeh Najmi Varzaneh et al.
ACTA NEUROLOGICA BELGICA (2014)
Iron depletion induced by bloodletting and followed by rhEPO administration as a therapeutic strategy in progressive multiple sclerosis: A pilot, open-label study with neurophysiological measurements
A. Creange et al.
NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY (2013)
Review: Recombinant human erythropoietin: novel strategies for neuroprotective/neuroregenerative treatment of multiple sclerosis
Claudia Bartels et al.
Therapeutic Advances in Neurological Disorders (2008)
Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis
Hannelore Ehrenreich et al.
BRAIN (2007)
Share Paper
